| Symbol | Name | Last Close | Mkt Cap | DailyStocks' Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
|
Vote Now! Monday’s Close |
|---|---|---|---|---|---|
| TEVA | Teva Pharmaceutical Industries Limited | $23.43 | $23.86B | N/A |
Mallinckrodt's StrataGraft Tissue Phase III Data Positive
http://www.zacks.com/stock/news/533490/mallinckrodts-stratagraft-tissue-phase-iii-data-positive?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-533490
Sep 24, 2019 - Mallinckrodt's (MNK) experimental StrataGraft regenerative tissue meets goals in a late-stage study for the treatment of burns.
0
Teva Won't Find Relevancy Through Cannabis
https://seekingalpha.com/article/4293240-teva-find-relevancy-cannabis?source=feed_tag_israel
Sep 24, 2019 - Israel’s Teva Pharmaceutical Industries Ltd. share price sells a notch above its 19 years low. Investor sentiment is low too. I do not recommend retail investors buy this stock now.TEVA still has sign
0
AstraZeneca's Fasenra Gets FDA Nod for Self-Administration
http://www.zacks.com/stock/news/552912/astrazenecas-fasenra-gets-fda-nod-for-self-administration?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-552912
Oct 07, 2019 - The FDA approval of the self-administration option and auto-injector of AstraZeneca's (AZN) Fasenra is supported by data from the phase III GRECO study and the phase I AMES study
0
Teva Pharmaceutical Industries Ltd. (TEVA) Gains As Market Dips: What You Should Know
http://www.zacks.com/stock/news/553574/teva-pharmaceutical-industries-ltd-teva-gains-as-market-dips-what-you-should-know?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-553574
Oct 07, 2019 - Teva Pharmaceutical Industries Ltd. (TEVA) closed at $6.98 in the latest trading session, marking a +0.14% move from the prior day.
0
Cramer's lightning round: MGM's gambling and sports plans are 'spectacular'
https://www.cnbc.com/2019/10/11/cramer-lightning-round-mgm-has-spectacular-gambling-sports-plans.html
Oct 11, 2019 - Jim Cramer takes calls and opines on viewer stock picks of the day in rapid speed.
0
Jim Cramer Shares His Thoughts On Teva Pharmaceutical, MGM Resorts And More
http://feeds.benzinga.com/~r/benzinga/~3/ggRLhSSoZus/jim-cramer-shares-his-thoughts-on-teva-pharmaceutical-mgm-resorts-and-more
Oct 12, 2019 -
On CNBC's "Mad Money Lightning Round," Jim Cramer said he doesn't like Teva Pharmaceutical Industries Ltd (NYSE: TEVA). He would sell the stock.
0
J&J (JNJ) Beats on Q3 Earnings as Sales Rise, Ups 2019 View
http://www.zacks.com/stock/news/565810/jj-jnj-beats-on-q3-earnings-as-sales-rise-ups-2019-view?cid=CS-ZC-FT-analyst_blog|earnings_article-565810
Oct 15, 2019 - J&J (JNJ) comes up with encouraging third-quarter 2019 results.
0
Here's Why Teva Pharmaceutical Soared Today
https://www.fool.com/investing/2019/10/21/heres-why-teva-pharmaceutical-soared-today.aspx?source=iedfolrf0000001
Oct 21, 2019 - The company announced an unexpectedly favorable settlement in a lawsuit related to the opioid epidemic.
0
Teva Pharmaceutical shares surge after announcing global opioid settlement
https://www.cnbc.com/2019/10/21/teva-shares-surge-after-announcing-global-opioid-settlement.html
Oct 21, 2019 - Under that deal, Teva would donate $23 billion in opioid addiction treatment drugs and pay $250 million over 10 years.
0
Teva's proposed opioid settlement could cost drugmaker pennies on the dollar
https://www.cnbc.com/2019/10/24/tevas-proposed-opioid-settlement-could-cost-drugmaker-pennies-on-the-dollar.html
Oct 24, 2019 - Teva Pharmaceutical's proposed $23 billion drug giveaway to settle thousands of U.S. opioid lawsuits will likely cost the company a fraction of that figure due to how it has valued those medicines, according to a Reuters review.
0